These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26482620)

  • 21. Direct measurement of DNA bending by type IIA topoisomerases: implications for non-equilibrium topology simplification.
    Hardin AH; Sarkar SK; Seol Y; Liou GF; Osheroff N; Neuman KC
    Nucleic Acids Res; 2011 Jul; 39(13):5729-43. PubMed ID: 21421557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting the DNA-topoisomerase complex in a double-strike approach with a topoisomerase inhibiting moiety and covalent DNA binder.
    Kurzwernhart A; Kandioller W; Bartel C; Bächler S; Trondl R; Mühlgassner G; Jakupec MA; Arion VB; Marko D; Keppler BK; Hartinger CG
    Chem Commun (Camb); 2012 May; 48(40):4839-41. PubMed ID: 22498692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topoisomerase II-alfa gene as a predictive marker of response to anthracyclines in breast cancer.
    Almeida D; Gerhard R; Leitão D; Davilla C; Damasceno M; Schmitt F
    Pathol Res Pract; 2014 Oct; 210(10):675-9. PubMed ID: 25042383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EGCG regulates the cross-talk between JWA and topoisomerase IIα in non-small-cell lung cancer (NSCLC) cells.
    Li Y; Shen X; Wang X; Li A; Wang P; Jiang P; Zhou J; Feng Q
    Sci Rep; 2015 Jun; 5():11009. PubMed ID: 26046674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA topoisomerase IIalpha predicts progression-free and overall survival in pediatric malignant non-brainstem gliomas.
    Bredel M; Pollack IF; Hamilton RL; Birner P; Hainfellner JA; Zentner J
    Int J Cancer; 2002 Jun; 99(6):817-20. PubMed ID: 12115482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Her-2/neu and topoisomerase IIα in advanced breast cancer: a comprehensive FISH analysis of 245 cases.
    Engelstaedter V; Schiffers J; Kahlert S; Mainka P; Engel J; Kirchner T; Diebold J; Mayr D
    Diagn Mol Pathol; 2012 Jun; 21(2):77-83. PubMed ID: 22555090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The ability of biomarkers to predict systemic progression in men with high-risk prostate cancer treated surgically is dependent on ERG status.
    Karnes RJ; Cheville JC; Ida CM; Sebo TJ; Nair AA; Tang H; Munz JM; Kosari F; Vasmatzis G
    Cancer Res; 2010 Nov; 70(22):8994-9002. PubMed ID: 21062978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topoisomerase II alpha protein and responsiveness of breast cancer to adjuvant chemotherapy with CEF compared to CMF in the NCIC CTG randomized MA.5 adjuvant trial.
    O'Malley FP; Chia S; Tu D; Shepherd LE; Levine MN; Huntsman D; Bramwell VH; Andrulis IL; Pritchard KI
    Breast Cancer Res Treat; 2011 Jul; 128(2):401-9. PubMed ID: 21519837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contribution of c-erbB-2 and topoisomerase IIalpha to chemoresistance in ovarian cancer.
    Hengstler JG; Lange J; Kett A; Dornhöfer N; Meinert R; Arand M; Knapstein PG; Becker R; Oesch F; Tanner B
    Cancer Res; 1999 Jul; 59(13):3206-14. PubMed ID: 10397267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The polyphenolic ellagitannin vescalagin acts as a preferential catalytic inhibitor of the α isoform of human DNA topoisomerase II.
    Auzanneau C; Montaudon D; Jacquet R; Puyo S; Pouységu L; Deffieux D; Elkaoukabi-Chaibi A; De Giorgi F; Ichas F; Quideau S; Pourquier P
    Mol Pharmacol; 2012 Jul; 82(1):134-41. PubMed ID: 22528119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical and two-parameter flow cytometric studies of DNA topoisomerase II alpha in human epithelial ovarian carcinoma and germ cell tumor.
    Tanoguchi K; Sasano H; Yabuki N; Kikuchi A; Ito K; Sato S; Yajima A
    Mod Pathol; 1998 Feb; 11(2):186-93. PubMed ID: 9504690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of p53 protein is a marker of poor prognosis in Mexican women with breast cancer.
    Dimas-González J; Maldonado-Lagunas V; Díaz-Chávez J; López-Arellano ME; Muñoz-Camacho J; Terán-Porcayo MA; Lagunas-Martínez A
    Oncol Rep; 2017 May; 37(5):3026-3036. PubMed ID: 28393224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topoisomerase II alpha--a fundamental prognostic factor in breast carcinoma.
    Hajduk M
    Pol J Pathol; 2009; 60(2):67-75. PubMed ID: 19886180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Value of urinary topoisomerase-IIA cell-free DNA for diagnosis of bladder cancer.
    Kim YH; Yan C; Lee IS; Piao XM; Byun YJ; Jeong P; Kim WT; Yun SJ; Kim WJ
    Investig Clin Urol; 2016 Mar; 57(2):106-12. PubMed ID: 26981592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topoisomerase 2 Alpha Cooperates with Androgen Receptor to Contribute to Prostate Cancer Progression.
    Schaefer-Klein JL; Murphy SJ; Johnson SH; Vasmatzis G; Kovtun IV
    PLoS One; 2015; 10(11):e0142327. PubMed ID: 26560244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and biological activity of ferrocenyl indeno[1,2-c]isoquinolines as topoisomerase II inhibitors.
    Wambang N; Schifano-Faux N; Aillerie A; Baldeyrou B; Jacquet C; Bal-Mahieu C; Bousquet T; Pellegrini S; Ndifon PT; Meignan S; Goossens JF; Lansiaux A; Pélinski L
    Bioorg Med Chem; 2016 Feb; 24(4):651-60. PubMed ID: 26740155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the predictive value of topoisomerase II alpha in patients with breast carcinoma.
    Hajduk M; Olszewski WP; Smietana A
    Pol J Pathol; 2009; 60(3):115-23. PubMed ID: 20069504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of Tumor-Infiltrating Lymphocytes and the Expression of Topoisomerase IIα in the Prediction of the Clinical Outcome of Patients with Triple-Negative Breast Cancer after Taxane-Anthracycline-Based Neoadjuvant Chemotherapy.
    Rao N; Qiu J; Wu J; Zeng H; Su F; Qiu K; Wu J; Yao H
    Chemotherapy; 2017; 62(4):246-255. PubMed ID: 28472798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A-62176, a potent topoisomerase inhibitor, inhibits the expression of human epidermal growth factor receptor 2.
    Kim HL; Jeon KH; Jun KY; Choi Y; Kim DK; Na Y; Kwon Y
    Cancer Lett; 2012 Dec; 325(1):72-9. PubMed ID: 22732416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Predictive and Prognostic Role of Topoisomerase IIα and Tissue Inhibitor of Metalloproteinases 1 Expression in Locally Advanced Breast Carcinoma of Egyptian Patients Treated With Anthracycline-based Neoadjuvant Chemotherapy.
    El Rebey HS; Aiad HA; Abulkheir IL; Asaad NY; El-Wahed MM; Abulkasem FM; Mahmoud SF
    Appl Immunohistochem Mol Morphol; 2016 Mar; 24(3):167-78. PubMed ID: 25710584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.